Total Payments
$1,041
2024 Payments
$184.89
Companies
15
Transactions
68
Medicare Patients
7,513
Medicare Billing
$321,066
Payment Breakdown by Category
Food & Beverage$1,041 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,041 | 68 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $354.39 | 23 | $0 (2024) |
| Amgen Inc. | $272.17 | 18 | $0 (2024) |
| AbbVie Inc. | $75.28 | 4 | $0 (2023) |
| Abbott Laboratories | $60.04 | 3 | $0 (2024) |
| Lilly USA, LLC | $57.43 | 4 | $0 (2024) |
| Amarin Pharma Inc. | $54.85 | 4 | $0 (2022) |
| GlaxoSmithKline, LLC. | $29.41 | 2 | $0 (2023) |
| ARBOR PHARMACEUTICALS, INC. | $28.23 | 2 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $24.70 | 2 | $0 (2022) |
| PFIZER INC. | $17.08 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $184.89 | 11 | Amgen Inc. ($64.08) |
| 2023 | $342.72 | 23 | Amgen Inc. ($163.56) |
| 2022 | $246.52 | 16 | Novo Nordisk Inc ($108.93) |
| 2021 | $235.55 | 16 | Novo Nordisk Inc ($124.23) |
| 2020 | $30.96 | 2 | Novo Nordisk Inc ($16.98) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Diabetes Care | ||||||
| 06/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diabetes Care | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Inflammation | ||||||
| 06/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Inflammation | ||||||
| 05/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Obesity | ||||||
| 03/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Inflammation | ||||||
| 03/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: VACCINES | ||||||
| 01/05/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: GALLSTONES | ||||||
| 01/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Inflammation | ||||||
| 12/19/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Inflammation | ||||||
| 12/18/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Inflammation | ||||||
| 12/11/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Inflammation | ||||||
| 11/03/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Inflammation | ||||||
| 11/02/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Inflammation | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: VACCINES | ||||||
| 10/25/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Inflammation | ||||||
| 10/13/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Obesity | ||||||
| 10/09/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Inflammation | ||||||
| 09/22/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Inflammation | ||||||
| 09/19/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Diabetes | ||||||
| 09/18/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Inflammation | ||||||
| 09/08/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/30/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.72 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 2,414 | 3,214 | $296,981 | $107,013 |
| 2022 | 41 | 2,101 | 2,644 | $269,259 | $97,377 |
| 2021 | 39 | 1,884 | 2,273 | $241,192 | $99,168 |
| 2020 | 18 | 1,114 | 1,281 | $84,293 | $17,508 |
Total Patients
7,513
Total Services
9,412
Medicare Billing
$321,066
Procedure Codes
139
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 197 | 508 | $106,680 | $40,678 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 141 | 141 | $40,185 | $17,220 | 42.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $9,920 | $5,629 | 56.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 127 | 144 | $10,800 | $4,177 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 62 | $9,300 | $3,933 | 42.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 46 | 46 | $3,680 | $3,302 | 89.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 182 | 344 | $8,600 | $2,890 | 33.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 160 | 173 | $10,380 | $2,848 | 27.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 156 | 181 | $8,145 | $2,375 | 29.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $4,400 | $2,350 | 53.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 165 | 197 | $11,820 | $2,039 | 17.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $4,800 | $1,876 | 39.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 13 | 13 | $2,080 | $1,700 | 81.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 56 | 56 | $3,080 | $1,634 | 53.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 20 | $5,700 | $1,436 | 25.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 80 | 97 | $4,365 | $1,434 | 32.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 104 | 150 | $5,250 | $1,428 | 27.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 34 | 34 | $9,486 | $1,206 | 12.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 34 | 34 | $1,870 | $991.78 | 53.0% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 138 | 141 | $4,230 | $893.94 | 21.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 68 | $3,808 | $696.40 | 18.3% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 27 | 32 | $1,920 | $531.20 | 27.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 27 | 27 | $2,160 | $510.84 | 23.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 58 | 64 | $2,560 | $487.04 | 19.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 11 | 12 | $840.00 | $485.40 | 57.8% |
About Dr. Rajya Atluri, M.D
Dr. Rajya Atluri, M.D is a Family Medicine healthcare provider based in Leland, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871546796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rajya Atluri, M.D has received a total of $1,041 in payments from pharmaceutical and medical device companies, with $184.89 received in 2024. These payments were reported across 68 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,041).
As a Medicare-enrolled provider, Atluri has provided services to 7,513 Medicare beneficiaries, totaling 9,412 services with total Medicare billing of $321,066. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Leland, NC
- Active Since 05/19/2006
- Last Updated 04/15/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1871546796
Products in Payments
- Otezla (Drug) $240.32
- Ozempic (Drug) $98.68
- Saxenda (Drug) $63.22
- MOUNJARO (Drug) $57.43
- Vascepa (Drug) $54.85
- Wegovy (Drug) $47.56
- FREESTYLE LIBRE 3 (Device) $46.98
- VRAYLAR (Drug) $42.23
- Aimovig (Biological) $31.85
- Rybelsus (Drug) $31.13
- SHINGRIX (Biological) $29.41
- Horizant (Drug) $28.23
- Kerendia (Drug) $24.70
- RYBELSUS (Drug) $21.30
- VIBERZI (Drug) $18.25
- PREVNAR 20 (Biological) $17.08
- QULIPTA (Drug) $14.80
- NEXLETOL (Drug) $14.30
- Flexitouch Plus (Device) $14.05
- RELTONE 200 MG (Drug) $13.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Leland
Kira Alatar, Md, MD
Family Medicine — Payments: $6,634
Family Medicine $6,634
Robert Johnson, Md, MD
Family Medicine — Payments: $5,711
Family Medicine $5,711
Dr. Anette Bodoky, M.d, M.D
Family Medicine — Payments: $3,461
Family Medicine $3,461
Dr. Lekeshia Jarrett, Md, MD
Family Medicine — Payments: $2,607
Family Medicine $2,607
Gloria Vreeland, M.d, M.D
Family Medicine — Payments: $1,629
Family Medicine $1,629
Joana Carnahan, D.o, D.O
Family Medicine — Payments: $994.40
Family Medicine $994.40